PTPN11 and breast carcinoma: In this study, we introduced a GOF mutation into the SHP2 in breast cancer cell lines, and these cell lines were used to investigate the roles of GOF mutations in SHP2 in the malignant behaviours of mammary tumours in vitro and in vivo.